LRMR Annual EBITDA
-$41.45 M
-$5.24 M-14.47%
31 December 2023
Summary:
As of January 20, 2025, LRMR annual earnings before interest, taxes, depreciation & amortization is -$41.45 million, with the most recent change of -$5.24 million (-14.47%) on December 31, 2023. During the last 3 years, it has risen by +$1.20 million (+2.82%). LRMR annual EBITDA is now -79.15% below its all-time high of -$23.14 million, reached on December 31, 2019.LRMR EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LRMR Quarterly EBITDA
-$18.19 M
+$6.32 M+25.79%
30 September 2024
Summary:
As of January 20, 2025, LRMR quarterly earnings before interest, taxes, depreciation & amortization is -$18.19 million, with the most recent change of +$6.32 million (+25.79%) on September 30, 2024. Over the past year, it has increased by +$6.32 million (+25.79%). LRMR quarterly EBITDA is now -391.09% below its all-time high of -$3.70 million, reached on June 30, 2019.LRMR Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LRMR TTM EBITDA
-$73.44 M
-$7.93 M-12.10%
30 September 2024
Summary:
As of January 20, 2025, LRMR TTM earnings before interest, taxes, depreciation & amortization is -$73.44 million, with the most recent change of -$7.93 million (-12.10%) on September 30, 2024. Over the past year, it has dropped by -$7.93 million (-12.10%). LRMR TTM EBITDA is now -1882.64% below its all-time high of -$3.70 million, reached on June 30, 2019.LRMR TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LRMR EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.5% | +25.8% | -12.1% |
| 3 y3 years | +2.8% | +25.8% | -12.1% |
| 5 y5 years | -79.2% | +25.8% | -12.1% |
LRMR EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.5% | +17.3% | -140.6% | +25.8% | -110.8% | at low |
| 5 y | 5-year | -79.2% | +17.3% | -196.3% | +25.8% | -298.0% | at low |
| alltime | all time | -79.2% | +17.3% | -391.1% | +25.8% | -1882.6% | at low |
Larimar Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.19 M(-25.8%) | -$73.44 M(+12.1%) |
| June 2024 | - | -$24.51 M(+47.2%) | -$65.51 M(+29.6%) |
| Mar 2024 | - | -$16.65 M(+18.3%) | -$50.54 M(+21.9%) |
| Dec 2023 | -$41.45 M(+14.5%) | -$14.08 M(+37.2%) | -$41.45 M(+9.9%) |
| Sept 2023 | - | -$10.26 M(+7.5%) | -$37.73 M(+5.1%) |
| June 2023 | - | -$9.54 M(+26.3%) | -$35.90 M(+2.7%) |
| Mar 2023 | - | -$7.56 M(-27.0%) | -$34.96 M(-3.4%) |
| Dec 2022 | -$36.21 M(-27.8%) | -$10.36 M(+22.8%) | -$36.21 M(+3.9%) |
| Sept 2022 | - | -$8.44 M(-2.0%) | -$34.84 M(-19.1%) |
| June 2022 | - | -$8.61 M(-2.3%) | -$43.05 M(-8.2%) |
| Mar 2022 | - | -$8.80 M(-2.1%) | -$46.91 M(-6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$50.14 M(+17.6%) | -$9.00 M(-45.9%) | -$50.14 M(-9.6%) |
| Sept 2021 | - | -$16.64 M(+33.5%) | -$55.49 M(+12.9%) |
| June 2021 | - | -$12.47 M(+3.6%) | -$49.13 M(+2.3%) |
| Mar 2021 | - | -$12.03 M(-16.1%) | -$48.03 M(+12.6%) |
| Dec 2020 | -$42.65 M(+84.3%) | -$14.35 M(+39.5%) | -$42.65 M(+23.8%) |
| Sept 2020 | - | -$10.29 M(-9.5%) | -$34.44 M(+5.1%) |
| June 2020 | - | -$11.37 M(+70.9%) | -$32.76 M(+30.5%) |
| Mar 2020 | - | -$6.65 M(+8.4%) | -$25.10 M(+36.0%) |
| Dec 2019 | -$23.14 M | -$6.14 M(-28.7%) | -$18.45 M(+49.9%) |
| Sept 2019 | - | -$8.61 M(+132.4%) | -$12.31 M(+232.4%) |
| June 2019 | - | -$3.70 M | -$3.70 M |
FAQ
- What is Larimar Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Larimar Therapeutics?
- What is Larimar Therapeutics annual EBITDA year-on-year change?
- What is Larimar Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly EBITDA year-on-year change?
- What is Larimar Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Larimar Therapeutics?
- What is Larimar Therapeutics TTM EBITDA year-on-year change?
What is Larimar Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of LRMR is -$41.45 M
What is the all time high annual EBITDA for Larimar Therapeutics?
Larimar Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$23.14 M
What is Larimar Therapeutics annual EBITDA year-on-year change?
Over the past year, LRMR annual earnings before interest, taxes, depreciation & amortization has changed by -$5.24 M (-14.47%)
What is Larimar Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of LRMR is -$18.19 M
What is the all time high quarterly EBITDA for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.70 M
What is Larimar Therapeutics quarterly EBITDA year-on-year change?
Over the past year, LRMR quarterly earnings before interest, taxes, depreciation & amortization has changed by +$6.32 M (+25.79%)
What is Larimar Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of LRMR is -$73.44 M
What is the all time high TTM EBITDA for Larimar Therapeutics?
Larimar Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.70 M
What is Larimar Therapeutics TTM EBITDA year-on-year change?
Over the past year, LRMR TTM earnings before interest, taxes, depreciation & amortization has changed by -$7.93 M (-12.10%)